ResearcherUniversity of LiègeActive in the last 2 years
Rebekah Crake
Matched on ORCID iD 0000-0002-0886-2487; OpenAlex author ID A5068735400. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 4
- Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. Co-author DOI 10.1038/s44318-025-00570-6↗
- Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Pancreatic Cancer Co-author DOI 10.1101/2025.07.07.663493↗
- Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Co-author DOI 10.3390/cells12101414↗
- Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer. Co-author DOI 10.3390/cancers15010061↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Akeila Bellahcène · 4 shared papers, 2022–2025 · strength 0.74
- Paper Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. DOI 10.1038/s44318-025-00570-6↗
- Paper Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Panc… DOI 10.1101/2025.07.07.663493↗
- Paper Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer. DOI 10.3390/cancers15010061↗
- Raphaël Peiffer · 3 shared papers, 2022–2025 · strength 0.54
- Paper Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. DOI 10.1038/s44318-025-00570-6↗
- Paper Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer. DOI 10.3390/cancers15010061↗
- Paper Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. DOI 10.3390/cells12101414↗
- Olivier Peulen · 3 shared papers, 2022–2025 · strength 0.54
- Paper Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. DOI 10.1038/s44318-025-00570-6↗
- Paper Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer. DOI 10.3390/cancers15010061↗
- Paper Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. DOI 10.3390/cells12101414↗
- Charlotte Gullo · 2 shared papers, 2022–2025 · strength 0.39
- Oier Azurmendi Senar · 2 shared papers, 2023–2025 · strength 0.35
- Tatjana Arsenijevic · 2 shared papers, 2023–2025 · strength 0.35
- Gilles Rademaker · 1 shared paper, 2025 · strength 0.21
- Atsushi Masamune · 1 shared paper, 2025 · strength 0.21
- Jean-Luc Van-Laethem · 1 shared paper, 2025 · strength 0.20
- Julie Navez · 1 shared paper, 2025 · strength 0.20
- Thierry Conroy · 1 shared paper, 2025 · strength 0.20
- Pieter Demetter · 1 shared paper, 2025 · strength 0.20
- Rémy Nicolle · 1 shared paper, 2025 · strength 0.20
- Jerome F. Cros · 1 shared paper, 2025 · strength 0.20
- Christelle Bouchart · 1 shared paper, 2025 · strength 0.20
- Kosta Stosic · 1 shared paper, 2025 · strength 0.20
- Nicky D’Haene · 1 shared paper, 2023 · strength 0.15
- Jean‐Luc Van Laethem · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.